Analysis and Distribution of Etoposide in Rat Brain Tumor Model: Intracarotid Versus Intracarotid with Angiotensin II—Induced Hypertension

References

• Suzuki M, Hori K, Abe I. A new approach to cancer chemotherapy: Selective enhancement of tumor blood flow with angiotensin II. JNCI 1981; 67: 563–669
   PubMedGoogle Scholar
• Sasaki Y, Imaoka S, Hasegawa Y. Changes in distribution of hepatic blood flow induced by intraarterial infusion of angiotensin It in human hepatic cancer. Cancer 1985; 55: 311–316
   PubMed Web of Science ®Google Scholar
• Ogasawara H, Kiya K, Kurisu K. Selective enhancement of tumor blood flow and drug delivery to brain tumors in experimental rat gliornas under angiotensin II-induced hypertension. Brain and Nerve (Tokyo) 1991; 43: 557–662, in Japanese
   Google Scholar
• Mitsuhata N, Seki M, Hino N. Intraarterial cis-diam-minedichloroplatinuni and angiotensin II infusion chemotherapy in patients with metastatic brain tumor or advanced bladder cancer. Recent advances in chemotherapy. Proc of the 14th International Congress of Chemotherapy. Anticancer Section 1985; 1: 395–396
   Google Scholar
• Tirelli U, D'lncalci M, Canetta R. Etoposide (VP-16–213) in malignant brain tumors: A phase II study. J Clin Oncol 1984; 2: 432–437
   PubMed Web of Science ®Google Scholar
• Kovnar E H, Keliie S J, Horowitz M E. Preirradiation cis-platin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: A phase II study. J Clin Oncol 1990; 8: 330–336
   PubMed Web of Science ®Google Scholar
• Corden B J, Strduss L C, Killmond T. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. J Neuro-Oncol 1991; 11: 57–63
   PubMed Web of Science ®Google Scholar
• Benda R G, Molnar P, Holowitz M. Morphological and immunochernicdl studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg 1971; 34: 310–323
   PubMed Web of Science ®Google Scholar
• Ldzu G, Yazawa Y, Tachibana M. Determination of etoposide in plasma by high performance liquid chromatography with fluorescence detector. Clin Rep 1989; 23: 479–483, in Japanese
   Google Scholar
• Rapoport S I, Fredericks W R, Ohno K. Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol 1980; 235: 421–423
   Google Scholar
• Inoue T, Fukui Nishio M. S. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumors. J Neurosurg 1987; 66: 256–263
   PubMed Web of Science ®Google Scholar
• Yamada K, Hayakawa T R, Ushio Y. Regional blood flow and capillary permeability in the methylnitrosourea-induced rat glioma. J Neurosurg 1981; 55: 922–928
   PubMed Web of Science ®Google Scholar
• Stewart D J, Richard M T, Hugenholtz H. Penetration of VP-16 (etoposidej into human intracerebral and extracerebral tumors. J Neuro-Oncol 1984; 2: 133–139
   PubMed Web of Science ®Google Scholar
• Rapoport S I, Hori M, Klatzo I. Testing of a hypothesis for osmotic opening of the blood-brain barrier. Am J Physiol 1972; 223: 323–331
   PubMed Web of Science ®Google Scholar
• Neuwelt E A, Diehl J T, Vu L H. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain banier disruption. Ann lntem Med 1981; 94: 449–454
   PubMed Web of Science ®Google Scholar
• Neuwelt E A, Bamett D A, Frenkel E P. Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: Observation on problems of drug delivery. Neurosurgery 1984; 14: 154–160
   PubMed Web of Science ®Google Scholar
• Shapiro WR., Voorhies R M, Hiesiger EM. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain bamer and blood-tumor barriers in rat brain tumors: A quantitative autoradiographic study. Cancer Res 1988; 48: 694–701
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Groothuis D, Blasberg R G. The effect of graded hypertonic intracarotid infusion on drug delivery to experimental RG-2 gliomas. Neurology 1984; 34: 1571–1581
   PubMed Web of Science ®Google Scholar
• Stahelin H. Activity of a new glycosidic ligand derivative (VP 16–213) related to podophyllotoxin in experimental tumor. Eur J Cancer 1973; 9: 215–224
   PubMed Web of Science ®Google Scholar
• Allen L M. Comparison of uptake and binding of two epi-dophyllotoxin glucopyranoside 4′-demethylepipodophyllotoxin ethylidene B-D-glucoside in the L1210 leukemia cell. Cancer Res 1978; 38: 2549–2554
   PubMedGoogle Scholar
• Evans W E, Sinkule J A, Crom W R. Pharmacokinetics of teniposide (VM-26) and etoposide (VP 16–213) in children with cancer. Cancer Chemother Pharmacol 1982; 7: 147–150
   PubMed Web of Science ®Google Scholar
• Feun L G, Lee Y Y, Yung W KA. Intracarotid VP-16 in malignant brain tumors. J Neuro-Oncol 1987; 4: 397–401
   PubMed Web of Science ®Google Scholar
• Colombo T, Broggini M, Torti L. Pharmacokinetics of VP 16–213 in Lewis lung carcinoma bearing mice. Cancer Chemother Pharmacol 1982; 7: 127–131
   PubMed Web of Science ®Google Scholar
• D'lncalci M, Farina P, Sessa C. Pharmacokinetics of VP 16–213 given by different methods. Cancer Chemother Pharmacol 1982; 7: 141–145
   PubMed Web of Science ®Google Scholar
• Suzuki M, Hori K, Abe I. Functional characterization of the microcircuration in tumors. Cancer Metastasis Rev 1984; 3: 115–126
   PubMed Web of Science ®Google Scholar
• Rapoport S I. Experimental modification of blood-brain barrier permeability by hypertonic solutions, convulsions, hypercapnia and acute hypertension. Fluid Environment of the Brain, HF Cserr, JD Fenstermacher, V Fencl. Academic Press., New York 1975; 61–80
   Google Scholar
• Bradbury M. The Concept of a Blood-Brain Barrier. Wiley, Chichester 1979; 351–382
   Google Scholar
• Spigelman M K, Zappulla R A, Strduchen J A. Etoposidc-induced blood-brain banier disruption in rats: Duration of opening and histological sequelae. Cancer Res 1986; 46: 1453–1457
   PubMed Web of Science ®Google Scholar
• Ogasawara H, Kiya K, Kurisu K. Effect of intracarotid infusion of etoposide with angiotensin II-induced hypertcnsion on the blood-brain barrier and the brain tissue. J Neuro-Oncol 1992; 13: 111–117
   PubMed Web of Science ®Google Scholar